Industry Research Reports

Home > Reports > Medical Care > Alzheimer's Treatment Drugs - Global Market Insights and Sales Trends 2024

Alzheimer's Treatment Drugs - Global Market Insights and Sales Trends 2024

Industry: Medical Care

Published: 2023-12-21

Pages: 101 Pages

Report ld: 1984008

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Alzheimer's Treatment Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Treatment Drugs in various end use industries. The expanding demands from the Online Sales and Offline Sales, are propelling Alzheimer's Treatment Drugs market. Cholinesterase Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the N-Methyl-D-Aspartate (NMDA) Receptor Antagonist segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alzheimer's Treatment Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Alzheimer's Treatment Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Alzheimer's Treatment Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alzheimer's Treatment Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Alzheimer's Treatment Drugs covered in this report include Eisai Co., Ltd., Novartis AG, Abbvie inc. (Allergan Plc), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, DAIICHI SANKYO COMPANY, LIMITED and Johnson & Johnson Services Inc, etc.

The global Alzheimer's Treatment Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Report Metric
Details
Report Title
Alzheimer's Treatment Drugs - Global Market Insights and Sales Trends 2024
Global Alzheimer's Treatment Drugs Companies Covered
Eisai Co., Ltd., Novartis AG, Abbvie inc. (Allergan Plc), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, DAIICHI SANKYO COMPANY, LIMITED, Johnson & Johnson Services Inc, TauRx Pharmaceuticals Ltd, F. Hoffmann La Roche Ltd.
Global Alzheimer's Treatment Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alzheimer's Treatment Drugs Market, Segment by Type
Cholinesterase Inhibitors

N-Methyl-D-Aspartate (NMDA) Receptor Antagonist

Combination Drug

Others
Global Alzheimer's Treatment Drugs Market, Segment by Application
Online Sales

Offline Sales
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alzheimer's Treatment Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Table of Contents

 1 Market Overview of Alzheimer's Treatment Drugs
    1.1 Alzheimer's Treatment Drugs Market Overview
        1.1.1 Alzheimer's Treatment Drugs Product Scope
        1.1.2 Alzheimer's Treatment Drugs Market Status and Outlook
    1.2 Global Alzheimer's Treatment Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Alzheimer's Treatment Drugs Market Size by Region (2018-2029)
    1.4 Global Alzheimer's Treatment Drugs Historic Market Size by Region (2018-2023)
    1.5 Global Alzheimer's Treatment Drugs Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Alzheimer's Treatment Drugs Market Size (2018-2029)
        1.6.1 North America Alzheimer's Treatment Drugs Market Size (2018-2029)
        1.6.2 Europe Alzheimer's Treatment Drugs Market Size (2018-2029)
        1.6.3 Asia-Pacific Alzheimer's Treatment Drugs Market Size (2018-2029)
        1.6.4 Latin America Alzheimer's Treatment Drugs Market Size (2018-2029)
        1.6.5 Middle East & Africa Alzheimer's Treatment Drugs Market Size (2018-2029)

 2 Alzheimer's Treatment Drugs Market by Type
    2.1 Introduction
        2.1.1 Cholinesterase Inhibitors
        2.1.2 N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
        2.1.3 Combination Drug
        2.1.4 Others
    2.2 Global Alzheimer's Treatment Drugs Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Alzheimer's Treatment Drugs Historic Market Size by Type (2018-2023)
        2.2.2 Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Alzheimer's Treatment Drugs Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Alzheimer's Treatment Drugs Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Alzheimer's Treatment Drugs Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Alzheimer's Treatment Drugs Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Alzheimer's Treatment Drugs Revenue Breakdown by Type (2018-2029)

 3 Alzheimer's Treatment Drugs Market Overview by Application
    3.1 Introduction
        3.1.1 Online Sales
        3.1.2 Offline Sales
    3.2 Global Alzheimer's Treatment Drugs Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Alzheimer's Treatment Drugs Historic Market Size by Application (2018-2023)
        3.2.2 Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Alzheimer's Treatment Drugs Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Alzheimer's Treatment Drugs Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Alzheimer's Treatment Drugs Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Alzheimer's Treatment Drugs Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Alzheimer's Treatment Drugs Revenue Breakdown by Application (2018-2029)

 4 Alzheimer's Treatment Drugs Competition Analysis by Players
    4.1 Global Alzheimer's Treatment Drugs Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2022)
    4.3 Date of Key Players Enter into Alzheimer's Treatment Drugs Market
    4.4 Global Top Players Alzheimer's Treatment Drugs Headquarters and Area Served
    4.5 Key Players Alzheimer's Treatment Drugs Product Solution and Service
    4.6 Competitive Status
        4.6.1 Alzheimer's Treatment Drugs Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 Eisai Co., Ltd.
        5.1.1 Eisai Co., Ltd. Profile
        5.1.2 Eisai Co., Ltd. Main Business
        5.1.3 Eisai Co., Ltd. Alzheimer's Treatment Drugs Products, Services and Solutions
        5.1.4 Eisai Co., Ltd. Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.1.5 Eisai Co., Ltd. Recent Developments
    5.2 Novartis AG
        5.2.1 Novartis AG Profile
        5.2.2 Novartis AG Main Business
        5.2.3 Novartis AG Alzheimer's Treatment Drugs Products, Services and Solutions
        5.2.4 Novartis AG Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.2.5 Novartis AG Recent Developments
    5.3 Abbvie inc. (Allergan Plc)
        5.3.1 Abbvie inc. (Allergan Plc) Profile
        5.3.2 Abbvie inc. (Allergan Plc) Main Business
        5.3.3 Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Products, Services and Solutions
        5.3.4 Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.3.5 Adamas Pharmaceuticals, Inc. Recent Developments
    5.4 Adamas Pharmaceuticals, Inc.
        5.4.1 Adamas Pharmaceuticals, Inc. Profile
        5.4.2 Adamas Pharmaceuticals, Inc. Main Business
        5.4.3 Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Products, Services and Solutions
        5.4.4 Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.4.5 Adamas Pharmaceuticals, Inc. Recent Developments
    5.5 H. Lundbeck A/S
        5.5.1 H. Lundbeck A/S Profile
        5.5.2 H. Lundbeck A/S Main Business
        5.5.3 H. Lundbeck A/S Alzheimer's Treatment Drugs Products, Services and Solutions
        5.5.4 H. Lundbeck A/S Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.5.5 H. Lundbeck A/S Recent Developments
    5.6 Biogen
        5.6.1 Biogen Profile
        5.6.2 Biogen Main Business
        5.6.3 Biogen Alzheimer's Treatment Drugs Products, Services and Solutions
        5.6.4 Biogen Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.6.5 Biogen Recent Developments
    5.7 AC Immune
        5.7.1 AC Immune Profile
        5.7.2 AC Immune Main Business
        5.7.3 AC Immune Alzheimer's Treatment Drugs Products, Services and Solutions
        5.7.4 AC Immune Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.7.5 AC Immune Recent Developments
    5.8 DAIICHI SANKYO COMPANY, LIMITED
        5.8.1 DAIICHI SANKYO COMPANY, LIMITED Profile
        5.8.2 DAIICHI SANKYO COMPANY, LIMITED Main Business
        5.8.3 DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Products, Services and Solutions
        5.8.4 DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.8.5 DAIICHI SANKYO COMPANY, LIMITED Recent Developments
    5.9 Johnson & Johnson Services Inc
        5.9.1 Johnson & Johnson Services Inc Profile
        5.9.2 Johnson & Johnson Services Inc Main Business
        5.9.3 Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Products, Services and Solutions
        5.9.4 Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.9.5 Johnson & Johnson Services Inc Recent Developments
    5.10 TauRx Pharmaceuticals Ltd
        5.10.1 TauRx Pharmaceuticals Ltd Profile
        5.10.2 TauRx Pharmaceuticals Ltd Main Business
        5.10.3 TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Products, Services and Solutions
        5.10.4 TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.10.5 TauRx Pharmaceuticals Ltd Recent Developments
    5.11 F. Hoffmann La Roche Ltd.
        5.11.1 F. Hoffmann La Roche Ltd. Profile
        5.11.2 F. Hoffmann La Roche Ltd. Main Business
        5.11.3 F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Products, Services and Solutions
        5.11.4 F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Revenue (US$ Million) & (2018-2023)
        5.11.5 F. Hoffmann La Roche Ltd. Recent Developments

 6 North America
    6.1 North America Alzheimer's Treatment Drugs Market Size by Country (2018-2029)
    6.2 United States
    6.3 Canada

 7 Europe
    7.1 Europe Alzheimer's Treatment Drugs Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Alzheimer's Treatment Drugs Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Alzheimer's Treatment Drugs Market Dynamics
    11.1 Alzheimer's Treatment Drugs Industry Trends
    11.2 Alzheimer's Treatment Drugs Market Drivers
    11.3 Alzheimer's Treatment Drugs Market Challenges
    11.4 Alzheimer's Treatment Drugs Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

Table of Figures

List of Tables
    Table 1. Global Market Alzheimer's Treatment Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Alzheimer's Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Alzheimer's Treatment Drugs Market Size Share by Region (2018-2023)
    Table 4. Global Alzheimer's Treatment Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Alzheimer's Treatment Drugs Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Alzheimer's Treatment Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Alzheimer's Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2018-2023)
    Table 9. Global Alzheimer's Treatment Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Alzheimer's Treatment Drugs Revenue Market Share by Type (2024-2029)
    Table 11. North America Alzheimer's Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Alzheimer's Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Alzheimer's Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Alzheimer's Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Alzheimer's Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Alzheimer's Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Alzheimer's Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Alzheimer's Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Alzheimer's Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Alzheimer's Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Alzheimer's Treatment Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Alzheimer's Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Alzheimer's Treatment Drugs Revenue Market Share by Application (2018-2023)
    Table 24. Global Alzheimer's Treatment Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Alzheimer's Treatment Drugs Revenue Market Share by Application (2024-2029)
    Table 26. North America Alzheimer's Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Alzheimer's Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Alzheimer's Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Alzheimer's Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Alzheimer's Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Alzheimer's Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Alzheimer's Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Alzheimer's Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Alzheimer's Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Alzheimer's Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Alzheimer's Treatment Drugs Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Alzheimer's Treatment Drugs Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drugs as of 2022)
    Table 39. Date of Key Players Enter into Alzheimer's Treatment Drugs Market
    Table 40. Global Alzheimer's Treatment Drugs Key Players Headquarters and Area Served
    Table 41. Alzheimer's Treatment Drugs Product Solution and Service
    Table 42. Global Alzheimer's Treatment Drugs Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Eisai Co., Ltd. Basic Information List
    Table 45. Eisai Co., Ltd. Description and Business Overview
    Table 46. Eisai Co., Ltd. Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of Eisai Co., Ltd. (2018-2023)
    Table 48. Eisai Co., Ltd. Recent Developments
    Table 49. Novartis AG Basic Information List
    Table 50. Novartis AG Description and Business Overview
    Table 51. Novartis AG Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of Novartis AG (2018-2023)
    Table 53. Novartis AG Recent Developments
    Table 54. Abbvie inc. (Allergan Plc) Basic Information List
    Table 55. Abbvie inc. (Allergan Plc) Description and Business Overview
    Table 56. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of Abbvie inc. (Allergan Plc) (2018-2023)
    Table 58. Abbvie inc. (Allergan Plc) Recent Developments
    Table 59. Adamas Pharmaceuticals, Inc. Basic Information List
    Table 60. Adamas Pharmaceuticals, Inc. Description and Business Overview
    Table 61. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of Adamas Pharmaceuticals, Inc. (2018-2023)
    Table 63. Adamas Pharmaceuticals, Inc. Recent Developments
    Table 64. H. Lundbeck A/S Basic Information List
    Table 65. H. Lundbeck A/S Description and Business Overview
    Table 66. H. Lundbeck A/S Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of H. Lundbeck A/S (2018-2023)
    Table 68. H. Lundbeck A/S Recent Developments
    Table 69. Biogen Basic Information List
    Table 70. Biogen Description and Business Overview
    Table 71. Biogen Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of Biogen (2018-2023)
    Table 73. Biogen Recent Developments
    Table 74. AC Immune Basic Information List
    Table 75. AC Immune Description and Business Overview
    Table 76. AC Immune Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of AC Immune (2018-2023)
    Table 78. AC Immune Recent Developments
    Table 79. DAIICHI SANKYO COMPANY, LIMITED Basic Information List
    Table 80. DAIICHI SANKYO COMPANY, LIMITED Description and Business Overview
    Table 81. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of DAIICHI SANKYO COMPANY, LIMITED (2018-2023)
    Table 83. DAIICHI SANKYO COMPANY, LIMITED Recent Developments
    Table 84. Johnson & Johnson Services Inc Basic Information List
    Table 85. Johnson & Johnson Services Inc Description and Business Overview
    Table 86. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of Johnson & Johnson Services Inc (2018-2023)
    Table 88. Johnson & Johnson Services Inc Recent Developments
    Table 89. TauRx Pharmaceuticals Ltd Basic Information List
    Table 90. TauRx Pharmaceuticals Ltd Description and Business Overview
    Table 91. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of TauRx Pharmaceuticals Ltd (2018-2023)
    Table 93. TauRx Pharmaceuticals Ltd Recent Developments
    Table 94. F. Hoffmann La Roche Ltd. Basic Information List
    Table 95. F. Hoffmann La Roche Ltd. Description and Business Overview
    Table 96. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Alzheimer's Treatment Drugs Business of F. Hoffmann La Roche Ltd. (2018-2023)
    Table 98. F. Hoffmann La Roche Ltd. Recent Developments
    Table 99. North America Alzheimer's Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 100. North America Alzheimer's Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 101. Europe Alzheimer's Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 102. Europe Alzheimer's Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 103. Asia-Pacific Alzheimer's Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 104. Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 105. Asia-Pacific Alzheimer's Treatment Drugs Market Size by Region (2024-2029) & (US$ Million)
    Table 106. Asia-Pacific Alzheimer's Treatment Drugs Market Share by Region (2018-2023)
    Table 107. Asia-Pacific Alzheimer's Treatment Drugs Market Share by Region (2024-2029)
    Table 108. Latin America Alzheimer's Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 109. Latin America Alzheimer's Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 110. Latin America Alzheimer's Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 111. Middle East & Africa Alzheimer's Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 112. Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 113. Middle East & Africa Alzheimer's Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 114. Alzheimer's Treatment Drugs Market Trends
    Table 115. Alzheimer's Treatment Drugs Market Drivers
    Table 116. Alzheimer's Treatment Drugs Market Challenges
    Table 117. Alzheimer's Treatment Drugs Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimer's Treatment Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Alzheimer's Treatment Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Alzheimer's Treatment Drugs Market Share by Regions: 2022 VS 2029
    Figure 4. Global Alzheimer's Treatment Drugs Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Alzheimer's Treatment Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Alzheimer's Treatment Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Alzheimer's Treatment Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Alzheimer's Treatment Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Alzheimer's Treatment Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Cholinesterase Inhibitors
    Figure 11. Global Cholinesterase Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
    Figure 13. Global N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Combination Drug
    Figure 15. Global Combination Drug Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Others
    Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Global Alzheimer's Treatment Drugs Market Size Share by Type:  2022 & 2029
    Figure 19. North America Alzheimer's Treatment Drugs Revenue Market Share by Type (2018-2029)
    Figure 20. Europe Alzheimer's Treatment Drugs Revenue Market Share by Type (2018-2029)
    Figure 21. Asia-Pacific Alzheimer's Treatment Drugs Revenue Market Share by Type (2018-2029)
    Figure 22. Latin America Alzheimer's Treatment Drugs Revenue Market Share by Type (2018-2029)
    Figure 23. Middle East and Africa Alzheimer's Treatment Drugs Revenue Market Share by Type (2018-2029)
    Figure 24. Online Sales Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Offline Sales Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Global Alzheimer's Treatment Drugs Market Size Share by Application: 2022 & 2029
    Figure 27. North America Alzheimer's Treatment Drugs Revenue Market Share by Application (2018-2029)
    Figure 28. Europe Alzheimer's Treatment Drugs Revenue Market Share by Application (2018-2029)
    Figure 29. Asia-Pacific Alzheimer's Treatment Drugs Revenue Market Share by Application (2018-2029)
    Figure 30. Latin America Alzheimer's Treatment Drugs Revenue Market Share by Application (2018-2029)
    Figure 31. Middle East and Africa Alzheimer's Treatment Drugs Revenue Market Share by Application (2018-2029)
    Figure 32. Alzheimer's Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 33. Global Top 5 and Top 10 Players Alzheimer's Treatment Drugs Market Share in 2022
    Figure 34. North America Alzheimer's Treatment Drugs Market Share by Country (2018-2029)
    Figure 35. United States Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 36. Canada Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 37. Germany Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 38. France Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 39. U.K. Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 40. Italy Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 41. Russia Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 42. Nordic Countries Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 43. Asia-Pacific Alzheimer's Treatment Drugs Market Share by Region (2018-2029)
    Figure 44. China Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 45. Japan Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 46. South Korea Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 47. Southeast Asia Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 48. India Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 49. Australia Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 50. Latin America Alzheimer's Treatment Drugs Market Share by Country (2018-2029)
    Figure 51. Mexico Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 52. Brazil Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 53. Middle East & Africa Alzheimer's Treatment Drugs Market Share by Country (2018-2029)
    Figure 54. Turkey Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 56. UAE Alzheimer's Treatment Drugs Market Size (2018-2029) & (US$ Million)
    Figure 57. Bottom-up and Top-down Approaches for This Report

Description

The global Alzheimer's Treatment Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Treatment Drugs in various end use industries. The expanding demands from the Online Sales and Offline Sales, are propelling Alzheimer's Treatment Drugs market. Cholinesterase Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the N-Methyl-D-Aspartate (NMDA) Receptor Antagonist segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Market Segmentation

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alzheimer's Treatment Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Industry: Medical Care

Published: 2023-12-21

Pages: 101 Pages

Report ld: 1984008

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License